Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2005The Breast Journal

Histopathologic Characteristics Predicting HER-2/neu Amplification in Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRaquel PratiSASophia K. AppleCity Of Hope National Medical CenterJHJianbo HeGuangzhou University of Chinese Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Prati et al. (2005) studied this question.

synapsesocial.com/papers/6a869b45bf8a68ea2b6ed697https://doi.org/10.1111/j.1075-122x.2005.00125.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Do we need HER‐2/<i>neu</i> testing for all patients with primary breast carcinoma?2003 · 101 citations
  2. 2HER-2/neu Protein Expression in Breast Cancer Evaluated by Immunohistochemistry2000 · 111 citations
  3. 3Assessment of HER‐2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?2003 · 40 citations
  4. 4correlation between histologic grade of malignancy and copy number of c-erbb-2 gene in breast carcinoma. A retrospective analysis of 176 cases1990 · 152 citations
  5. 5Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene1987 · 11,839 citations